Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FHNT7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,844
Award facts
- Contract value 100% obligated
- $11,844.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,844.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a contract valued at approximately $500 million and extending through December 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier for Department of Defense healthcare operations, leveraging its established position within DLA's broader $30.3 billion PPV-G GEN V acquisition strategy to provide branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The award of Xolair, an immunosuppressant biologic agent, exemplifies the company's role in delivering specialized pharmaceutical products essential to federal military medical system operations. No subcontractor relationships are identified in the award documentation, with performance to be executed at the contractor's Park Ridge, Illinois location.
Quick answers
Who was awarded contract SPE2DR26FHNT7?
SPE2DR26FHNT7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FHNT7 worth?
The government has obligated $11,844 on SPE2DR26FHNT7.
Is contract SPE2DR26FHNT7 an order under another contract?
Yes. SPE2DR26FHNT7 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNT7 competed?
The extent of competition for SPE2DR26FHNT7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award